Quintiles to boost early-phase testing lab with Advion Biosciences acquisition
Quintiles says it will buy US bioanalytical lab Advion BioServices citing a pharmaceutical industry shift towards more thorough laboratory testing as motivation.
Quintiles says it will buy US bioanalytical lab Advion BioServices citing a pharmaceutical industry shift towards more thorough laboratory testing as motivation.
CMO Aenova says demand for contract manufacturing capacity in Europe is increasing.
Icon will this year focus its R&D efforts on gaining new grounds in genomics, said Brian O’Dwyer.Icon
Medimetrics is collaborating with Bio-Images to offer its electronic targeted drug delivery tech to clinical researchers.
BASF says solubility and bioavailability will be key focus for its pharmaceutical excipient product development efforts in the next few years.
Aptamers and dendrimers can revitalise the faltering siRNA sector by solving delivery problems, AAPS panelists said.